The cost of generalized anxiety disorder in primary care settings: Results of the ANCORA study

Community Mental Health Journal

Volumn 48, Issue 3, 2012, Pages 372-383

  Rovira, Joan ^a   Albarracin, Guillermina ^b   Salvador, Luis ^c   Rejas, Javier ^d   Sánchez Iriso, Eduardo ^e   Cabasés, Juan M ^e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b University of Sydney ^*  (Spain)

^c UNIVERSITY OF SYDNEY   (Australia)

^d PFIZER INC   (United States)

^e PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

Cost of illness; Costs; Generalized anxiety disorder; Primary care; Productivity

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; CASE CONTROL STUDY; COST OF ILLNESS; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MALE; MENTAL HEALTH SERVICE; MIDDLE AGED; PRIMARY HEALTH CARE; PRODUCTIVITY; RETROSPECTIVE STUDY; SICKNESS IMPACT PROFILE; SOCIOECONOMICS; SPAIN; STATISTICS;

ADOLESCENT; ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CASE-CONTROL STUDIES; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EFFICIENCY; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS; SPAIN; YOUNG ADULT;

EID: 84864838081     PISSN: 00103853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10597-012-9503-4     Document Type: Article

References (35)

1. Alonso, J., Angermeyer, M. C., Bernert, S., et al. (2004). Prevalence of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica Supplementum, 420, 21-27.
2. Andlin-Sobocki, P., & Wittchen, H. U. (2005). Cost of affective disorders in Europe. European Journal of Neurology, 12(Suppl 1), 34-38.
3. Berndt, E. R., Bailit, H. L., Keller, M. B., Verner, J. C., & Finkelstein, S. N. (2000). Health care use and at-work productivity among employees with mental disorders. Health Affaires (Millwood), 19, 244-256.
4. Boada, M., Pena-Casanova, J., Bermejo, F., et al. (1999). Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain. Medicina Clinica (Barc), 113, 690-695.
5. Candilis, P. J., & Pollack, M. H. (1997). The hidden costs of untreated anxiety disorders. Harvard Review of Psychiatry, 5, 40-42.
6. Catálogo de Especialidades Farmacéuticas de. (2006). Consejo General de Colegios Oficiales de Farmacéuticos de España. Madrid 2006.
7. Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373-383.
8. Chocron Bentata, L., Vilalta Franch, J., Legazpi Rodriguez, I., Auquer, K., & Franch, L. (1995). Prevalence of psychopathology at a primary care center. Atencion Primaria, 16, 586-590.
9. Dolan, P. (1996). Modelling valuation for health states: The effect of duration. Health Policy, 38, 189-203.
10. Fricchione, G. (2004). Clinical practice. Generalized anxiety disorder. New England Journal of Medicine, 351, 675-682.
11. Gilks, W. R., Richardson, S., & y Spiegelhalter, D. J. (1996). Markov chain Monte Carlo in practice. London: Chapman and Hall.
12. Goldberg, D., & Lecrubier, Y. (1995). Form and frequency of mental disorders across centres. In T. Üstün & N. Sartorius (Eds.), Mental illness in general health care: An international study (pp. 323-334). New York: Wiley.
13. Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
14. Haro, J. M., Salvador-Carulla, L., Cabases, J., Madoz, V., & Vazquez-Barquero, J. L. (1998). Utilisation of mental health services and costs of patients with schizophrenia in three areas of Spain. British Journal of Psychiatry, 173, 334-340.
15. INE. (2006). Encuesta trimestral de coste laboral. Notas de Prensa. September 20, 2006. Available from: http://www.ine.es/daco/daco42/etcl/etcl0206. pdf. Accessed 28 January 2007.
16. Lieb, R., Becker, E., & Altamura, C. (2005). The epidemiology of generalized anxiety disorder in Europe. European Neuropsychopharmacology, 15, 445-452.
17. Lobo, A., & Campos, R. (1997). Los trastornos de ansiedad en atención primaria. Madrid: EMISA.
18. Lobo, A., Chamorro, L., Luque, A., et al. (2002).Validation of theSpanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Medicina Clinica (Barc), 118, 493-499.
19. Lopez-Bastida, J., Serrano-Aguilar, P., & Duque-Gonzalez, B. (2004). Socio-economic costs of mental health in the Canary Islands, Spain, in 2002. Atencion Primaria, 34, 32-37.
20. Marciniak, M., Lage, M. J., Landbloom, R. P., Dunayevich, E., & Bowman, L. (2004). Medical and productivity costs of anxiety disorders: Case control study. Depress Anxiety, 19, 112-120.
21. NIMH. (2005). Generalized anxiety disorder (GAD). http://www.nimh.nih. gov/health/topics/generalized-anxiety-disorder-gad/index.shtml. Updated 2005. Accessed 21 Nov 2005.
22. O'Hagan, A., & Stevens, J. W. (2001). A framework for costeffectiveness analysis from clinical trial data. Health Economics, 10, 303-315.
23. Peiro, S., Gomez, G., Navarro, M., Guadarrama, I., & Rejas, J. (2004). Psychosp Group. Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain. Description and associated factors. The Psychosp study. Social Psychiatry and Psychiatric Epidemiology, 39, 507-513.
24. Quan, H., Sundararajan, V., Halfon, P., et al. (2005). Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care, 43, 1130-1139.
25. Saldivia Borquez, S., Torres Gonzalez, F., Cabases Hita, J. M., & PSICOST Group. (2005). Estimation of mental health care cost units for patients with schizophrenia. Actas Españolas de Psiquiatría, 33, 280-285.
26. Salvador-Carulla, L., Haro, J. M., Cabases, J., Madoz, V., Sacristan, J. A., Vazquez-Barquero, J. L., et al. (1999). Service utilization and costs of first-onset schizophrenia in two widely differing health service areas in north-east Spain. Acta Psychiatrica Scandinavica, 100, 335-343.
27. Salvador-Carulla, L., Segui, J., Fernandez-Cano, P., & Canet, J. (1995). Costs and offset effect in panic disorders. British Journal of Psychiatry Supplement, 27, 23-28.
28. Sicras, A., Rejas, J., Arco, S., et al. (2005). Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting. Dementia and Geriatric Cognitive Disorders, 19, 305-315.
29. SOIKOS Database. (2005). SOIKOS, Centro de Estudios en Economía de la Salud y Política Social. Base de datos de costes sanitarios. Versión 2.2. Barcelona 2005. http://www.soikos.com.
30. Souetre, E., Lozet, H., Cimarosti, I., et al. (1994). Cost of anxiety disorders: Impact of comorbidity. Journal of Psychosomatic Research, 38(Suppl 1), 151-160.
31. Spiegelhalter, D. J., Thomas, A., Best, N., & y Lunn, D. (2003). "WinBUGS user manual", Biostatistic Unit, Cambrige, UK. http://www.mrc-bsu.cam.ac.uk/bugs.
32. Vazquez-Polo, F. J., Negrin, M., Cabases, J. M., Sanchez, E., Haro, J. M., & Salvador-Carulla, L. (2005). An analysis of the costs of treating schizophrenia in Spain: A hierarchical Bayesian approach. Journal of Mental Health Policy and Economics, 8, 153-165.
33. Wittchen, H. U. (2002). Generalized anxiety disorder: Prevalence, burden, and cost to society. Depress Anxiety, 16, 162-171.
34. Wittchen, H. U., Zhao, S., Kessler, R. C., & Eaton, W. W. (1994). DSM-III-R generalized anxiety disorder in the national comorbidity survey. Archives of General Psychiatry, 51, 355-364.
35. World Health Organization. (1992). ICD-10: The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines, Geneva.